Incannex Healthcare (IXHL) Intangibles (2022 - 2023)

Incannex Healthcare (IXHL) posted quarterly Intangibles of $52.7 million for Q2 2023, little changed on a QoQ basis from $52.7 million in Q4 2022.

Incannex Healthcare (IXHL) Intangibles (2022 - 2023) Analysis & Trends

Incannex Healthcare (IXHL) has reported Intangibles for 2 consecutive years, with $52.7 million the latest figure, recorded in Q2 2023.

  • Quarterly Intangibles changed N/A year-over-year to $52.7 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $52.7 million (changed N/A YoY) and the FY2023 annual result came in at $52.7 million, changed N/A from the prior year.
  • Intangibles steadied at $52.7 million in Q2 2023 per IXHL's latest filing, from $52.7 million in the prior quarter.
  • Over the last five years, Intangibles for IXHL reached as high as $52.7 million in Q4 2022 and fell as low as $52.7 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 34.07 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 3.61 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 959.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 21.80 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 473.93 Mn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 14.48 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.23 Bn
10 Incannex Healthcare 3.63 Mn 3.63 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 52.72 Mn
Dec 31, 2022 52.72 Mn